YYZ Pharmatech Inc.

Profile

YYZPharmatech Inc. (“YYZ”) reveals and validates novel, proximal, functional co-receptor drug targets from the surface of ligand-activated live human cells – to meaningfully enable first-in-class biologic and small molecule treatments for patients. BCG estimates that 60% of pharma’s total projected global pipeline value is now important new modalities (i.e. msAbs, ADCs, CAR-T) – which all target cell surface proteins. Meanwhile, only a small percentage of the surfaceome is considered well-characterized. Target innovation is therefore a principal bottleneck in next-gen drug development – and YYZ’s novel technologies bridge this critical gap. YYZ is a member of JLABS, BioLabs and many of Canada’s leading accelerators and consortia. Our scientific foundation is built on the pioneering research of Dr. John G. Marshall, over 150 publications and extensive collaboration with leading international institutions.

yyz pharmatech inc.
yyzpharmatech.com

Contact

Event details

Date: June 22 - 25, 2026

Event contact

Patricia Cosgrove
Senior International Market Consultant
U.S.A. & Europe

Participants

23 in total
  • 20/20 OptimEyes Technologies
    20/20 OptimEyes Technologies is developing OPT-101, a once-weekly, non-invasive glaucoma eye drop designed to…
  • Altis Labs
    Altis Labs is the computational imaging company accelerating clinical trials with AI endpoints.…
  • BioScript Solutions
    BioScript Solutions is a Canadian healthcare company committed to simplifying access to specialty care. BioScript…
  • Biotherapeutics Manufacturing Centre
    The Ottawa Hospital's Biotherapeutics Manufacturing Centre(BMC) is a cell and gene therapy…
  • Custom Biologics
    Custom Biologics provides regulatory compliant potency testing and assay services for all phases of…
  • Dalriada Drug Discovery
    Dalriada is a Canadian small molecule discovery company focusing on unlocking challenging and undruggable targets…
  • Eurofins CDMO Alphora
    Located in Mississauga, Ontario, Eurofins CDMO Alphora delivers comprehensive solutions for small…
  • Everest Clinical Research
    Founded in 2004, Everest Clinical Research is a full-service contract research organization with more than 750…
  • HDAX Therapeutics
    HDAX Therapeutics develops next-gen HDAC6 inhibitors for…
  • i-RNA Corporation
    i-RNA Corporation is a preclinical biotech developing siRNA…
  • ImmunoBiochem Corporation
    ImmunoBiochem is a pharma-partnered biotech developing novel degrader-antibody conjugate (DAC)…
  • Medicenna Therapeutics
    Medicenna is a clinical stage immunotherapy company developing novel and highly differentiated engineered long-…
  • Noa Therapetuics
    Noa Therapeutics is pioneering a breakthrough to the Aryl Hydrocarbon Receptor (AhR), a commercially…
  • Nucro-Technics
    Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both…
  • Paradox Immunotherapeutics
    Paradox Immunotherapeutics is a venture-backed, clinical-inflection biotech tackling protein misfolding diseases…
  • PharmAla Biotech
    PharmAla Biotech (CSE:…
  • PlantForm Corporation
    PlantForm develops and manufactures proteins, antibodies, and vaccines at low cost using its green, plant-based…
  • Q&C Services
    For over 32 years, Q&C Services has been Canada’s largest privately owned pharmaceutical consulting firm. Its…
  • QurCan Therapeutics Inc.
    QurCan Therapeutics is advancing the next wave of genetic medicines for CNS…
  • Spiderwort Biotechnologies Inc.
    Spiderwort Biotechnologies is a clinical-stage regenerative medicine company pioneering a differentiated class of…
  • Sussex Research Laboratories Inc.
    Sussex Research Laboratories Inc. (Ottawa, Canada) is a globally recognized specialist in Empowering Therapeutic…
  • SYNG Pharmaceuticals Inc
    SYNG has developed, EndoID a new first-in-class diagnostic test for Endometriosis. It is…
  • YYZ Pharmatech Inc.
    YYZPharmatech Inc. (“YYZ”) reveals and validates novel, proximal, functional co-receptor drug…